-

Agilent Launches New Advanced Dilution System to Increase Lab Efficiency

Addressing the growing need for complete ICP-MS and ICP-OES workflow automation in the lab

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.

The Agilent ADS 2 is an intelligent autodilutor designed to enhance laboratory workflows. Designed to integrate seamlessly with Agilent autosamplers, ICP-OES and ICP-MS instruments and software, it offers a fully integrated, single-supplier automated solution.

As one of the most trusted brands in the analytical instrumentation market, Agilent worked with a wide range of customers to address key barriers to autodilution adoption. The result is an easy to install, highly efficient and robust solution for production environments, utilizing unique flow path technology to optimize the speed of analysis for both diluted and undiluted samples, and the same software as the instrument to ensure consistency and traceability in data handling and reporting.

“We understand that the ability to enhance lab productivity without compromising quality or profitability is of utmost importance to our customers,” stated Keith Bratchford, vice president and general manager of Agilent's Atomic Spectroscopy Division. “Agilent’s comprehensive automation system establishes us as the exclusive provider capable of meeting the needs of routine food, environmental, and pharmaceutical testing laboratories. Furthermore, the ADS 2 will have significant applications in the advanced materials market, particularly in battery research, differentiating us from our competitors.”

Agilent’s single-vendor approach offers a seamless and attractive alternative for our valued customers, resulting in simplified data management, and increased productivity.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Media Contact
Catherine Kaye
Agilent Technologies
+44 (0)7775 410632
catherine.kaye@agilent.com

Agilent Technologies Inc.

NYSE:A

Release Versions

Contacts

Media Contact
Catherine Kaye
Agilent Technologies
+44 (0)7775 410632
catherine.kaye@agilent.com

More News From Agilent Technologies Inc.

Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of Aarhus University, Professor Walter Gössler of University of Graz, and Professor Gregory Offer of Imperial College London. These separate awards recognize their outstanding contributions to battery research. Developing new materials for more efficient and durable batteries is essential to reducing fossil fuel rel...

Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These are the first HPLC systems on the market to feature the new Agilent InfinityLab Assist Technology, offering enhanced, built-in system assistance capabilities. This technology allows...

Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse domains—from basic research to drug discovery and therapy development. The NovoCyte Opteon represents a significant leap forward in flow cytometry technology, with configurations ranging from...
Back to Newsroom